A panel drug test is a screening that checks for a specific number of substance categories at once, with the number in the name telling you exactly how many. A 5-panel test screens for five drug classes, a 10-panel screens for ten, and so on. The most common version is the 5-panel test, which is the standard for federal and transportation workplace screening. Employers, courts, and medical providers choose the panel size based on how broad a screen they need.
How the Panel Number Works
The number is straightforward: it corresponds to the number of drug classes being tested. A “class” can cover multiple related substances. The opioid panel, for instance, doesn’t just detect one drug. It picks up morphine, codeine, hydrocodone, oxycodone, and fentanyl, among others. So even a basic 5-panel test is actually screening for dozens of individual compounds grouped into five categories.
Employers and testing organizations can customize which classes appear on their panel. Two different 6-panel tests from two different companies might not screen for exactly the same things. The exception is federally mandated testing, where the substance list is locked in by regulation.
What a 5-Panel Test Covers
The standard 5-panel drug test, required by the U.S. Department of Transportation for safety-sensitive workers like truck drivers and pilots, screens for:
- Marijuana (THC)
- Cocaine
- Amphetamines (including methamphetamine and MDMA)
- Opioids (including heroin, morphine, codeine, oxycodone, hydrocodone, and fentanyl)
- Phencyclidine (PCP)
This is the most widely used panel in the United States. If someone tells you they had a “standard drug test” for a job, it was likely this one.
What Larger Panels Add
A 10-panel test includes everything in the 5-panel and adds five more categories. The additional classes typically include benzodiazepines (anti-anxiety medications like Xanax and Valium), barbiturates (older sedatives like phenobarbital), methadone, methaqualone, and propoxyphene. Some 10-panel configurations swap one of these for MDMA (ecstasy) as a separate line item rather than grouping it under amphetamines.
Panels of 12 or more exist and generally layer on additional prescription drug categories or synthetic opioids. The higher the panel number, the more likely it is to catch prescription medication use alongside illicit substances. Courts and pain management clinics tend to order these broader screens, while most private employers stick with 5 or 10.
How the Test Actually Works
Most panel drug tests use a two-step process. The first step is a rapid screening called an immunoassay, which works by detecting whether a substance or its byproducts are present above a set threshold. This is the quick, relatively inexpensive part. For a urine test, the initial threshold for marijuana is 50 nanograms per milliliter (ng/mL), while cocaine’s threshold is 150 ng/mL and amphetamines sit at 500 ng/mL.
If the initial screen comes back positive, the sample goes through a second, more precise analysis using a technique called mass spectrometry. This confirmatory step is highly reliable and uses lower cutoff levels to verify the result. For marijuana, the confirmatory cutoff drops to 15 ng/mL. This two-tier system exists because the initial immunoassay can sometimes flag substances that aren’t actually there.
A substance present in your system but below the cutoff concentration will be reported as negative. You don’t need to have zero traces of a substance to pass. You need to be below the threshold.
Urine, Oral Fluid, and Detection Windows
Urine is the most common sample type for panel testing, but oral fluid (saliva) testing is increasingly used and is now authorized for federal workplace programs. The two methods have different cutoff levels and detect substances over different time frames. Oral fluid testing uses much lower initial thresholds. Marijuana’s oral fluid cutoff is just 4 ng/mL compared to 50 ng/mL in urine, but oral fluid generally detects more recent use rather than use from days or weeks ago.
In urine, detection windows vary significantly by substance:
- Marijuana: 1 to 3 days after a single use, up to 30 days with chronic use
- Cocaine: Up to 4 days (the drug itself clears within a day, but its metabolite lingers)
- Opioids (morphine, codeine): 2 to 5 days
- Amphetamines: 2 to 5 days
These ranges depend on factors like metabolism, body fat percentage, hydration, and how frequently the substance was used. Marijuana is the most variable because THC is stored in fat tissue, meaning heavy users can test positive weeks after their last use while occasional users may clear it in a couple of days.
False Positives and Cross-Reactivity
The initial immunoassay screening is not perfect. Certain prescription and over-the-counter medications can trigger a false positive because their chemical structure resembles the target substance closely enough to trip the test.
Some of the most common culprits:
- Pseudoephedrine and phenylephrine (found in cold and sinus medications) can trigger the amphetamine panel
- Ibuprofen and naproxen have been associated with false positives for barbiturates and, less commonly, marijuana
- Diphenhydramine (Benadryl) can cross-react with the methadone and opiate panels
- Bupropion (an antidepressant and smoking-cessation aid) can trigger false positives for amphetamines
- Proton pump inhibitors (heartburn medications) have caused false positives on the marijuana panel
- Dextromethorphan (a common cough suppressant) can cross-react with the opioid panel
This is exactly why confirmatory testing exists. The mass spectrometry step can distinguish between the actual target drug and a structurally similar medication. If you’re taking a prescription or over-the-counter drug that might cause a false positive, you’ll typically have the opportunity to disclose it to a Medical Review Officer before a result is finalized. In DOT-regulated testing, a certified Medical Review Officer reviews every positive result and contacts the donor to determine whether a legitimate medical explanation exists.
Who Uses Which Panel
The panel size you encounter depends on the context. Federal agencies and DOT-regulated industries are locked into the 5-panel test by law, though the specific opioids covered within that panel have expanded over the years to include fentanyl. Private employers have more flexibility. Many stick with 5 panels to keep costs down, but industries with higher safety concerns or those in states with specific requirements may opt for 10 or more.
Courts and probation programs often use expanded panels because they’re monitoring for prescription drug misuse alongside illicit drug use. Pain management clinics use high-panel tests to verify that patients are taking their prescribed medications and not supplementing with other substances. In these clinical settings, the goal is sometimes the opposite of workplace testing: they want to confirm the presence of a prescribed drug, not just catch unauthorized ones.